ARTICLE | Company News
Evotec OAI AG deal
March 28, 2005 8:00 AM UTC
EVT's subsidiary, Evotec Neurosciences GmbH, in-licensed an undisclosed compound from an undisclosed company. The compound has completed a Phase I trial and EVT plans to develop it in a different CNS ...